A PRACTICAL SYNTHESIS OF 4-HYDROXYETHYL-2,3-DIHYDROBENZOFURAN
作者:Haining Gu、Wei Ming Xu
DOI:10.1080/00304940809458107
日期:2008.10
BENZOFURANS AND BENZOPYRANS AS CHRONOBIOLOGICAL AGENTS
申请人:GLAXO GROUP LIMITED
公开号:EP0901483A2
公开(公告)日:1999-03-17
US5981572A
申请人:——
公开号:US5981572A
公开(公告)日:1999-11-09
[EN] BENZOFURANS AND BENZOPYRANS AS CHRONOBIOLOGICAL AGENTS<br/>[FR] BENZOFURANS ET BENZOPYRANS UTILISES EN TANT QU'AGENTS CHRONOBIOLOGIQUES
申请人:——
公开号:WO1997043272A2
公开(公告)日:1997-11-20
[EN] A compound of formula (I), wherein R<1> and R<2> which may be the same or different represent H, C1-6 alkyl, C3-7 cycloalkyl or aryl; R<3>, and R<4> which may be the same or different represent H, halogen, C1-6 alkyl; or substituted aryl; R<5> represents H or C1-6 alkyl or; n is an integer 0, 1 or 2 and m is an integer 1, 2, 3 or 4; the dotted line indicates the presence or absence of an additional bond; and pharmaceutically acceptable solvates thereof. [FR] L'invention concerne un composé de formule (I) dans laquelle R<1> et R<2>, qui peuvent être identiques ou différents, représentent H, alkyle C1-6, aryle ou cycloalkyle C3-7; R<3> et R<4>, qui peuvent être identiques ou différents, représentent H, halogène, alkyle C1-6; ou aryle substitué; R<5> représente H ou alkyle C1-6 ou; n vaut 0, 1 ou 2 et m vaut 1, 2, 3 ou 4; la ligne pointillée indique la présence ou l'absence d'une liaison supplémentaire. Elle porte aussi sur des solvates dudit composé, acceptables sur le plan pharmaceutique.
Benzofurans and benzopyrans as chronobiological agents
申请人:Glaxo Wellcome Inc.
公开号:US05981572A1
公开(公告)日:1999-11-09
The invention thus provides compounds of Formula (I) ##STR1## wherein R.sup.1 and R.sup.2 which may be the same or different represent H, C.sub.1-6 alkyl or substituted alkyl or C.sub.3-7 cycloalkyl; or aryl; R.sup.3, and R.sup.4 which may be the same or different represent H, halogen, C.sub.1-6 alkyl; or substituted aryl; R.sup.5 is H or C.sub.1-6 alkyl; n is an integer 0, 1 or 2 and m is an integer 1, 2, 3, or 4; the dotted line indicates the presence or absence of an additional bond; and pharmaceutically acceptable solvates (e.g. hydrates) thereof.